December 20, 2024

Small HCQ Study Falls to Retraction

When combining hydroxychloroquine with azithromycin, researchers reported 100% virological cure by day 6 compared to 57.1% with hydroxychloroquine alone and 12.5% in controls - though the now-retracted study's small sample included just 6 patients receiving both drugs.

Conexiant

December 20, 2024

New Arthritis Findings Span Two Decades

New research reveals increased risk factors for psoriatic arthritis in patients with juvenile idiopathic arthritis over an 18-year study period in the Nordic region.

Conexiant

December 20, 2024

Long COVID Shows Five Distinct Patterns: Study

In the 2024 update, the NIH's RECOVER Initiative identified five distinct symptom patterns and new diagnostic thresholds for long COVID.

Conexiant

December 20, 2024

POI Guidelines See First Major Update Since 2015

Four medical societies have revised their diagnostic criteria for premature ovarian insufficiency, now requiring only one elevated FSH test instead of two, while reporting a higher than previously known prevalence rate of 3.5% among women.

Conexiant

December 19, 2024

Ancient DNA Still Affects Tooth Size Today

New research reveals that Neanderthal DNA variants in the HS3ST3A1 gene, which regulates tooth development and influences incisor width, persist in modern Europeans, providing the first molecular evidence linking archaic human genes to contemporary dental variation.

Conexiant

December 19, 2024

Large Acetaminophen Study Reveals New Risks

In a large cohort study of 180,483 acetaminophen users aged 65 or older, researchers found that use was associated with a 36% increased risk of lower gastrointestinal bleeding.

Conexiant

December 19, 2024

Comparing CBT Delivery Methods in Atopic Dermatitis

A new study published in JAMA Dermatology reveals that a self-guided online cognitive behavioral therapy program for atopic dermatitis was noninferior to clinician-guided treatment, offering promise for disseminating evidence-based psychological treatment for patients.

Conexiant

December 18, 2024

Darzalex May Delay Myeloma in High-Risk Patients

For the first time, we have a treatment option that can significantly delay or prevent the progression to active disease."

Reuters

December 18, 2024

Major Heart Failure Trial Yields Key Data

A recent multicenter trial investigated the impact of potassium nitrate supplementation on exercise capacity and quality of life in patients with heart failure with preserved ejection fraction, revealing interesting insights into blood nitric oxide metabolites.

Conexiant